These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 31816609)

  • 21. Analysis of volatile organic compounds in exhaled breath by gas chromatography-mass spectrometry combined with chemometric analysis.
    Dallinga JW; Smolinska A; van Schooten FJ
    Methods Mol Biol; 2014; 1198():251-63. PubMed ID: 25270934
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Analysis of volatile organic compounds in exhaled breath to diagnose ventilator-associated pneumonia.
    Schnabel R; Fijten R; Smolinska A; Dallinga J; Boumans ML; Stobberingh E; Boots A; Roekaerts P; Bergmans D; van Schooten FJ
    Sci Rep; 2015 Nov; 5():17179. PubMed ID: 26608483
    [TBL] [Abstract][Full Text] [Related]  

  • 23. T1rho MRI and CSF biomarkers in diagnosis of Alzheimer's disease.
    Haris M; Yadav SK; Rizwan A; Singh A; Cai K; Kaura D; Wang E; Davatzikos C; Trojanowski JQ; Melhem ER; Marincola FM; Borthakur A
    Neuroimage Clin; 2015; 7():598-604. PubMed ID: 25844314
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Application of Machine Learning to Arterial Spin Labeling in Mild Cognitive Impairment and Alzheimer Disease.
    Collij LE; Heeman F; Kuijer JP; Ossenkoppele R; Benedictus MR; Möller C; Verfaillie SC; Sanz-Arigita EJ; van Berckel BN; van der Flier WM; Scheltens P; Barkhof F; Wink AM
    Radiology; 2016 Dec; 281(3):865-875. PubMed ID: 27383395
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cluster analysis of volatile organic compounds - A pilot study in patients with severe acute decompensated heart failure.
    Butter L; Haase-Fielitz A; Zänker M; Becher G; Nübel J; Butter C
    J Cardiol; 2024 Aug; 84(2):146-148. PubMed ID: 38621579
    [TBL] [Abstract][Full Text] [Related]  

  • 26. On the importance of accurate quantification of individual volatile metabolites in exhaled breath.
    Smith D; Španěl P
    J Breath Res; 2017 Nov; 11(4):047106. PubMed ID: 28635619
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Monitoring of selected skin- and breath-borne volatile organic compounds emitted from the human body using gas chromatography ion mobility spectrometry (GC-IMS).
    Mochalski P; Wiesenhofer H; Allers M; Zimmermann S; Güntner AT; Pineau NJ; Lederer W; Agapiou A; Mayhew CA; Ruzsanyi V
    J Chromatogr B Analyt Technol Biomed Life Sci; 2018 Feb; 1076():29-34. PubMed ID: 29396365
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Volatile organic compounds (VOCs) for the non-invasive detection of pancreatic cancer from urine.
    Daulton E; Wicaksono AN; Tiele A; Kocher HM; Debernardi S; Crnogorac-Jurcevic T; Covington JA
    Talanta; 2021 Jan; 221():121604. PubMed ID: 33076134
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diagnostic differentiation of mild cognitive impairment due to Alzheimer's disease using a hippocampus-dependent test of spatial memory.
    Moodley K; Minati L; Contarino V; Prioni S; Wood R; Cooper R; D'Incerti L; Tagliavini F; Chan D
    Hippocampus; 2015 Aug; 25(8):939-51. PubMed ID: 25605659
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Peppermint protocol: first results for gas chromatography-ion mobility spectrometry.
    Ruszkiewicz DM; Myers R; Henderson B; Yusof H; Meister A; Moreno S; Eddleston M; Darnley K; Nailon WH; McLaren D; Lao YE; Hovda KE; Lam S; Cristescu SM; Thomas CLP
    J Breath Res; 2022 May; 16(3):. PubMed ID: 35508103
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Non-invasive detection of renal disease biomarkers through breath analysis.
    Khokhar M
    J Breath Res; 2024 Jan; 18(2):. PubMed ID: 38099568
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synaptic proteins in CSF as potential novel biomarkers for prognosis in prodromal Alzheimer's disease.
    Duits FH; Brinkmalm G; Teunissen CE; Brinkmalm A; Scheltens P; Van der Flier WM; Zetterberg H; Blennow K
    Alzheimers Res Ther; 2018 Jan; 10(1):5. PubMed ID: 29370833
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Confounding effect of benign pulmonary diseases in selecting volatile organic compounds as markers of lung cancer.
    Wang M; Sheng J; Wu Q; Zou Y; Hu Y; Ying K; Wan H; Wang P
    J Breath Res; 2018 Sep; 12(4):046013. PubMed ID: 30102249
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Volatile organic compounds (VOCs) in exhaled breath of patients with breast cancer in a clinical setting.
    Mangler M; Freitag C; Lanowska M; Staeck O; Schneider A; Speiser D
    Ginekol Pol; 2012 Oct; 83(10):730-6. PubMed ID: 23383557
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Detection of Alzheimer's and Parkinson's disease from exhaled breath using nanomaterial-based sensors.
    Tisch U; Schlesinger I; Ionescu R; Nassar M; Axelrod N; Robertman D; Tessler Y; Azar F; Marmur A; Aharon-Peretz J; Haick H
    Nanomedicine (Lond); 2013 Jan; 8(1):43-56. PubMed ID: 23067372
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A dual center study to compare breath volatile organic compounds from smokers and non-smokers with and without COPD.
    Gaida A; Holz O; Nell C; Schuchardt S; Lavae-Mokhtari B; Kruse L; Boas U; Langejuergen J; Allers M; Zimmermann S; Vogelmeier C; Koczulla AR; Hohlfeld JM
    J Breath Res; 2016 Apr; 10(2):026006. PubMed ID: 27082437
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Breath volatile organic compounds of lung transplant recipients with and without chronic lung allograft dysfunction.
    Küppers L; Holz O; Schuchardt S; Gottlieb J; Fuge J; Greer M; Hohlfeld JM
    J Breath Res; 2018 Jun; 12(3):036023. PubMed ID: 29771243
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evidence of endogenous volatile organic compounds as biomarkers of diseases in alveolar breath.
    Sarbach C; Stevens P; Whiting J; Puget P; Humbert M; Cohen-Kaminsky S; Postaire E
    Ann Pharm Fr; 2013 Jul; 71(4):203-15. PubMed ID: 23835018
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lap Time Variability From a 400-m Walk Is Associated With Future Mild Cognitive Impairment and Alzheimer's Disease.
    Tian Q; Resnick SM; Studenski SA; Ferrucci L
    J Am Med Dir Assoc; 2019 Dec; 20(12):1535-1539.e3. PubMed ID: 31227471
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Breath Analysis: Identification of Potential Volatile Biomarkers for Non-Invasive Diagnosis of Chronic Kidney Disease (CKD).
    Di Gilio A; Palmisani J; Nisi M; Pizzillo V; Fiorentino M; Rotella S; Mastrofilippo N; Gesualdo L; de Gennaro G
    Molecules; 2024 Oct; 29(19):. PubMed ID: 39407614
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.